Anzalone Christopher Richard
SEC insider (Form 3/4/5 filer). CIK 0001423029. Chief Executive Officer at ARROWHEAD PHARMACEUTICALS, INC. (ARWR). 46 reported Form 4/5 transactions since Sep 2024; latest on Jan 2, 2026. Located in PASADENA, CA.
Companies Anzalone Christopher Richard has filed insider reports for
- ARROWHEAD PHARMACEUTICALS, INC. (ARWR): Director, Officer, Chief Executive Officer
Anzalone Christopher Richard
CIK: 0001423029
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ARROWHEAD PHARMACEUTICALS, INC.
Discretionary Trading P&L
Holdings
Transaction History (46 total)
- Jan 2, 2026ARWR
ARROWHEAD PHARMACEUTICALS, INC.
SaleDirect7.4K shares at avg. $65.88$489K - Jan 2, 2026ARWR
ARROWHEAD PHARMACEUTICALS, INC.
SaleDirect5.8K shares at avg. $66.39$383K - Dec 29, 2025ARWR
ARROWHEAD PHARMACEUTICALS, INC.
ExerciseDirect16.5K shares at avg. $6.15$102K - Dec 29, 2025ARWR
ARROWHEAD PHARMACEUTICALS, INC.
SaleDirect35.2K shares at avg. $69.33$2.4M - Dec 29, 2025ARWR
ARROWHEAD PHARMACEUTICALS, INC.
ExerciseDirect35.2K shares at avg. $6.15$216K - Dec 29, 2025ARWR
ARROWHEAD PHARMACEUTICALS, INC.
SaleDirect16.5K shares at avg. $68.69$1.1M - Dec 22, 2025ARWR
ARROWHEAD PHARMACEUTICALS, INC.
SaleDirect2.6K shares at avg. $68.85$177K - Dec 22, 2025ARWR
ARROWHEAD PHARMACEUTICALS, INC.
SaleDirect10K shares at avg. $68.33$684K - Dec 19, 2025ARWR
ARROWHEAD PHARMACEUTICALS, INC.
SaleDirect8.1K shares at avg. $68.01$554K - Dec 19, 2025ARWR
ARROWHEAD PHARMACEUTICALS, INC.
SaleDirect4K shares at avg. $66.67$265K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jan 2, 2026 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | Sale | 7,416 | $65.88 | $488,566 | Direct |
| Jan 2, 2026 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | Sale | 5,771 | $66.39 | $383,137 | Direct |
| Dec 29, 2025 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | Exercise | 16,545 | $6.15 | $101,752 | Direct |
| Dec 29, 2025 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | Sale | 35,181 | $69.33 | $2,439,099 | Direct |
| Dec 29, 2025 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | Exercise | 35,181 | $6.15 | $216,363 | Direct |
| Dec 29, 2025 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | Sale | 16,545 | $68.69 | $1,136,476 | Direct |
| Dec 22, 2025 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | Sale | 2,574 | $68.85 | $177,220 | Direct |
| Dec 22, 2025 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | Sale | 10,012 | $68.33 | $684,120 | Direct |
| Dec 19, 2025 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | Sale | 8,147 | $68.01 | $554,077 | Direct |
| Dec 19, 2025 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | Sale | 3,979 | $66.67 | $265,280 | Direct |
1-10 of 46 transactions